Clinical Trials Directory

Trials / Unknown

UnknownNCT03062839

Melatonin as Adjuvant Treatment for ADHD in Adults

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Hospital Israelita Albert Einstein · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the effect of melatonin supplementation as adjuvant treatment in ADHD in adults.

Conditions

Interventions

TypeNameDescription
DRUGMelatonin 5 mgMelatonin 5 mg taken 30 minutes before bed time

Timeline

Start date
2017-09-01
Primary completion
2019-02-28
Completion
2019-06-30
First posted
2017-02-23
Last updated
2018-08-15

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03062839. Inclusion in this directory is not an endorsement.

Melatonin as Adjuvant Treatment for ADHD in Adults (NCT03062839) · Clinical Trials Directory